GSK3B and lung cancer: Our results suggest that fibulin-5 antagonizes Wnt signaling by inhibiting ERK and indirectly activating GSK3β to restrain β-catenin in the cytoplasm, which prevents MMP-7 and c-Myc expression and lung cancer cell invasion and proliferation (Fig. 7H).